These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11099478)

  • 1. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5.
    Zhang JC; Claffey K; Sakthivel R; Darzynkiewicz Z; Shaw DE; Leal J; Wang YC; Lu FM; McCrae KR
    FASEB J; 2000 Dec; 14(15):2589-600. PubMed ID: 11099478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides.
    Zhang JC; Qi X; Juarez J; Plunkett M; Donaté F; Sakthivel R; Mazar AP; McCrae KR
    Can J Physiol Pharmacol; 2002 Feb; 80(2):85-90. PubMed ID: 11934260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.
    Zhang JC; Donate F; Qi X; Ziats NP; Juarez JC; Mazar AP; Pang YP; McCrae KR
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12224-9. PubMed ID: 12196635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
    Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA
    Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
    McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
    Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.
    Katkade V; Soyombo AA; Isordia-Salas I; Bradford HN; Gaughan JP; Colman RW; Panetti TS
    Thromb Haemost; 2005 Sep; 94(3):606-14. PubMed ID: 16268479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kininostatin as an antiangiogenic inhibitor: what we know and what we do not know.
    Guo YL; Wang S; Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1931-40. PubMed ID: 12489806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.
    Sun D; McCrae KR
    Blood; 2006 Jun; 107(12):4714-20. PubMed ID: 16418331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
    Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
    FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
    Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
    Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen.
    Colman RW; Pixley RA; Sainz IM; Song JS; Isordia-Salas I; Muhamed SN; Powell JA; Mousa SA
    J Thromb Haemost; 2003 Jan; 1(1):164-70. PubMed ID: 12871554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
    Cao DJ; Guo YL; Colman RW
    Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen.
    Colman RW
    Int Immunopharmacol; 2002 Dec; 2(13-14):1887-94. PubMed ID: 12489802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.
    Liu Y; Sainz IM; Wu Y; Pixley R; Espinola RG; Hassan S; Khan MM; Colman RW
    Exp Cell Res; 2008 Feb; 314(4):774-88. PubMed ID: 18062965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
    Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
    Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen.
    Chavakis T; Boeckel N; Santoso S; Voss R; Isordia-Salas I; Pixley RA; Morgenstern E; Colman RW; Preissner KT
    J Biol Chem; 2002 Jun; 277(26):23157-64. PubMed ID: 11970955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
    Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
    Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.
    Guo YL; Colman RW
    J Thromb Haemost; 2005 Apr; 3(4):670-6. PubMed ID: 15733059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
    Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
    Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.
    Hassan S; Sainz IM; Khan MM; Bradford HN; Isordia-Salas I; Kashem SW; Sartor RB; Colman RW
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2959-65. PubMed ID: 17293494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.